SlideShare a Scribd company logo
1 of 22
Download to read offline
October 2017
Investor Review
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
This presentation contains forward-looking statements reflecting our current expectations that involve risks and uncertainties which are
subject to safe harbors under the Securities Act of 1933, as amended, or the Securities Act, and the Securities Exchange Act of 1934, as
amended, or the Exchange Act.
These forward-looking statements may include, but are not limited to, statements concerning our plans, objectives, expectations and
intentions, future financial position, future revenues, projected costs, expectations regarding demand and acceptance for our
technologies, growth opportunities and trends in the market in which we operate, prospects and plans and objectives of management.
The words “anticipates,” “believes,” “estimates," “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions
are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We
may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place
undue reliance on our forward-looking statements.
These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in
the forward-looking statements, including, without limitation, the risks set forth in Part II, Item 1A, “Risk Factors” in our Quarterly
Reports on Form 10-Q and in our other filings with the Securities and Exchange Commission. We do not assume any obligation to
update any forward-looking statements.
2
Forward-Looking Statements
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
VOCERA
We simplify and improve the lives of healthcare professionals,
patients, and families
A recognized
leader in clinical
communication
and workflow
solutions
Founded in 2000
HQ: San Jose, CA
~600 employees
40+ clinician staff
1,100 US Hospitals
1,400 Customers
99% Maintenance
Renewals
Proven ROI
20%+ Rev. Growth
Operating Leverage
Strong balance sheet
(NYSE: VCRA)
68 VA Hospitals
32 DoD Hospitals
JITC, DIACAP,
FIPS certified
©2017 Vocera Communications. All rights reserved.
3
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
4
• Large market shifting toward Vocera
• Market leader with compelling ROI
• Large wins validate sales strategy
• Software acquisition extends platform
• Accelerating operating leverage
*Earnings before interest, taxes, depreciation and amortization, and further excludes
stock -based compensation and change in fair value of warrant and option liabilities.
**Represents the high end of the company’s guidance range
Our Opportunity
$95
$104
$128
$162
-13%
-3%
3%
6%
-15%
-10%
-5%
0%
5%
10%
0
20
40
60
80
100
120
140
160
180
FY14 FY15 FY16 FY17 Guide - High
Revenue $M A-EBITDA %
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
(1) Joint Commission, an independent healthcare accreditation organization
(2) Agarwal et. al. Univ. of Maryland, 2010
92% of physicians use unsecured SMS text for
patient care, leading to data breeches and HIPAA
violations resulting in over $1.5M in fines per year
Efficient communication is a primary component
in driving patient engagement and satisfaction
Nurses often only spend 20% of their time
delivering direct care at the patient bedside
69% of accidental deaths and serious injuries in
hospitals are caused by communications breakdowns1
Cybercriminals
are increasingly going after targets in
the medical and healthcare verticals
$12 billion
wasted annually
In U.S. hospitals as a result of
communication inefficiencies2
5
Healthcare Communication Challenges
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
Vocera Before Vocera Now
Communications
Badge-Centric
Point Product
Department Sale
Clinical Workflow
Software-Centric
Complete Solution
Enterprise Sale
Strategic Evolution
6
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
7
10 minutes
per nurse per shift
Bed turnover
rates up 50%
OR revenues
up $780,000
350 more annual
OR capacity hours
4,000 annual ED
hours recaptured
Operational Efficiency
Response times down
from 2 minutes to
9 seconds
35% overall satisfaction
rating improvement
25% improvement
in HCAHPS scores
Fall related injuries
down 60%; estimated
$1.27 mm savings
Patient Safety and Satisfaction
Compelling Return on Investment
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
8
MEDCOM
Recent Platform Wins Validate Strategy
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
Quality ResiliencyPatient-CenteredCost
Enhance how care is
provided to help
patients to achieve
better outcomes
Increase
operational
efficiencies
Improve patient
experience by allowing
caregivers to be
Patient Centered
Improve the caregiver
experience by improving
workflow and empowering
care teams
The Quadruple Aim
9
Our Mission
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
10
Communicate Engage
Experience
Improve response
times, patient care,
safety and satisfaction
Over 120 clinical
integrations
Secure text,
voice, image
Clinical Communication and Collaboration
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
Vocera Platform Enables the Patient Journey
Clinical Communication
Smartphones and
Wearable Devices
Care ExperienceStaff Assignment
Alarm and Alert
Management
System Integration and
Interoperability
Security Compliance
The Patient Journey
Clinical Expertise Enterprise Grade, Scalable
Obtain,
clarify, change
orders
Patient
status
Test
results
Admission,
discharge,
transfer
Nurse-
physician
consult
Patient
Flow
11
Vocera’s Enterprise Approach
12
Today’s Situation
Product Vision - A Holistic, Enterprise Approach
Alerts
Alarms
Messaging
Voice
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
Communicate, Collaborate, Make Informed Decisions Quickly
PHYSICIAN
 Collaborate whether inside
or outside the hospital
NURSE
Reach the right person
without names or numbers
NURSE SUPERVISOR
Keep nurses and
patients safer
HOSPITALIST
Receive timely, relevant
patient information
HOUSEKEEPING
Increase bed turnover
Alert & Alarm
Intelligence
Electronic
Health Record
Nurse Call
Physiologic
Monitor
Bed
Management
Real-Time
Location System
Laboratory
Info System
INPUTS
Dynamic Data
Aggregation of Patient
Events and Context
OUTPUTS
Context-Aware Events
Response and Critical
Collaboration
Dynamic Master
Directory
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
Device of Choice Differentiator
Hands-Free BYOD or in House Tablet Desktop/ WOW
14
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
15
 Complete end-to-end solution
 Device of choice
 Hands-free
 Role-based intelligence
= we win > 75% of the time
 Enterprise Class
 Clinical integration
 Secure
 World class service/support
Competitive LandscapeStatusQuo
Wireless
Devices
Smartphone
Apps
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
6,986
Hospitals
in the U.S.(1)
U.S. Hospitals
1100+
(1)
Large Global Market Opportunity
(1 ) Based on Definitive US Healthcare Database. As of January 1, 2017
(2) Definitive Healthcare database
International
Healthcare Facilities
230+
Global Non-
Healthcare Facilities
270+
Fed Hospitals Vocera Total
VA 68 153
DoD 32 64
Total 100 217
~$6 Billion Global Market Opportunity
16
1108
5200
Vocera Hospitals US Hospitals
18% U.S. Penetration Rate
(2)
(6308 Total US Hospitals)
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
• Large system deals
• Further penetrate existing
health system customers
• Continue pace of new
customer acquisition
Building momentum
across new products
• EHR Integration
• Collaboration Suite
• Clinical Integration
• Event Driven Alerts
• Care Experience
Extend reach to new
users
• Physicians
• Long Term Care
• Surgery Centers
Attractive international
markets
• Canada
• United Kingdom
• Saudi Arabia
• UAE
• Qatar
• Australia
• New Zealand
Core Customer
Growth
Software
New Users
International
Expansion
17
Our Opportunity: Multiple Avenues for Growth
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
Software
*15%+ subscription
18
% of 2016
Revenue
16%
Maintenance
*All recurring
34%
Services
*15%+ recurring
11%
39%
Devices
*50%
recurring
Diversified Revenue, High Visibility
• 60% revenues are
recurring
• High visibility
• Low customer
concentration
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
(1) Earnings before interest, taxes, depreciation and amortization, and further excludes stock -based compensation and change in fair value of warrant and option liabilities.
Revenue Highlights
Adjusted EBITDA
$33.8 $42.3
$91.7
$117.0
Q316 Q317 YTD '16 YTD '17
($inMillions)
-$2.8
$4.3
2015 2016
($inMillions)
Strong Revenue Growth
• Q3’17: 25% Revenue Growth
• Product: +20%, Services: +32%
• YTD’17: 27% Revenue Growth
Solid Customer Base and Value Proposition
• 95%+ s/w maintenance renewal rate
• Strong competitive win rate
Expanding Profitability and Cash Flow
• 2017 A-EBITDA guidance: $7.0 -10.5 million
• $67.5 million of Cash, no Debt
19
+25% +27%
Financial Highlights
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
20
Q4’17 Revenue Visibility
Rev from Def. Rev/BL Supplies Visible Revenue Book-ship Q4'17 Revenue
$45M*
(*high end of guidance)
©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved.
21
Actual
2014 2015 2016
R&D % of Revenue 17% 15% 13%
S&M % of Revenue 47% 41% 37%
G&A % of Revenue 13% 12% 11%
Target Model
12%
29%
8%
Sales
Notes
• All numbers are non-GAAP
• Mean peer group enterprise value comps are 3-4x Revenue and 12-15x A-EBITDA
Drivers
Operating Leverage Drives Significant Value
Thank you!

More Related Content

What's hot

Investor Presentation
Investor PresentationInvestor Presentation
Investor Presentationvocera2016ir
 
Vocera investordeck august 2018 web version
Vocera investordeck  august 2018 web versionVocera investordeck  august 2018 web version
Vocera investordeck august 2018 web versionvocera2016ir
 
Vocera investordeck -june-2018-web
Vocera investordeck -june-2018-webVocera investordeck -june-2018-web
Vocera investordeck -june-2018-webvocera2016ir
 
Vocera investordeck december 2018 web
Vocera investordeck  december 2018 webVocera investordeck  december 2018 web
Vocera investordeck december 2018 webvocera2016ir
 
Vocera investordeck october 2018 web
Vocera investordeck  october 2018 webVocera investordeck  october 2018 web
Vocera investordeck october 2018 webvocera2016ir
 
Vocera investordeck may 25 web 2018
Vocera investordeck  may 25 web 2018Vocera investordeck  may 25 web 2018
Vocera investordeck may 25 web 2018vocera2016ir
 
Vocera investordeck september 2018 web
Vocera investordeck  september 2018 webVocera investordeck  september 2018 web
Vocera investordeck september 2018 webvocera2016ir
 
Vocera investordeck november 2018 web
Vocera investordeck  november 2018 webVocera investordeck  november 2018 web
Vocera investordeck november 2018 webvocera2016ir
 
Is Big Data a Big Deal... or Not?
Is Big Data a Big Deal... or Not?Is Big Data a Big Deal... or Not?
Is Big Data a Big Deal... or Not?Dale Sanders
 
Vocera investordeck may 25 web 2018
Vocera investordeck  may 25 web 2018Vocera investordeck  may 25 web 2018
Vocera investordeck may 25 web 2018vocera2016ir
 
Nvta investor overview may 2016
Nvta investor overview may 2016Nvta investor overview may 2016
Nvta investor overview may 2016invitaeir
 
Managing National Health: An Overview of Metrics & Options
Managing National Health: An Overview of Metrics & OptionsManaging National Health: An Overview of Metrics & Options
Managing National Health: An Overview of Metrics & OptionsDale Sanders
 
Microsoft: A Waking Giant in Healthcare Analytics and Big Data
Microsoft: A Waking Giant in Healthcare Analytics and Big DataMicrosoft: A Waking Giant in Healthcare Analytics and Big Data
Microsoft: A Waking Giant in Healthcare Analytics and Big DataDale Sanders
 
Investor Presentation
Investor PresentationInvestor Presentation
Investor Presentationvocera2016ir
 
Red Chip April Virtual Conf Investor Presentation April 2017
Red Chip April Virtual Conf Investor Presentation April 2017Red Chip April Virtual Conf Investor Presentation April 2017
Red Chip April Virtual Conf Investor Presentation April 2017RedChip Companies, Inc.
 
Vocera investordeck -may-15-2018web
Vocera investordeck -may-15-2018webVocera investordeck -may-15-2018web
Vocera investordeck -may-15-2018webvocera2016ir
 

What's hot (17)

Investor Presentation
Investor PresentationInvestor Presentation
Investor Presentation
 
Vocera investordeck august 2018 web version
Vocera investordeck  august 2018 web versionVocera investordeck  august 2018 web version
Vocera investordeck august 2018 web version
 
Vocera investordeck -june-2018-web
Vocera investordeck -june-2018-webVocera investordeck -june-2018-web
Vocera investordeck -june-2018-web
 
Vocera investordeck december 2018 web
Vocera investordeck  december 2018 webVocera investordeck  december 2018 web
Vocera investordeck december 2018 web
 
Vocera investordeck october 2018 web
Vocera investordeck  october 2018 webVocera investordeck  october 2018 web
Vocera investordeck october 2018 web
 
Vocera investordeck may 25 web 2018
Vocera investordeck  may 25 web 2018Vocera investordeck  may 25 web 2018
Vocera investordeck may 25 web 2018
 
Vocera investordeck september 2018 web
Vocera investordeck  september 2018 webVocera investordeck  september 2018 web
Vocera investordeck september 2018 web
 
Vocera investordeck november 2018 web
Vocera investordeck  november 2018 webVocera investordeck  november 2018 web
Vocera investordeck november 2018 web
 
Is Big Data a Big Deal... or Not?
Is Big Data a Big Deal... or Not?Is Big Data a Big Deal... or Not?
Is Big Data a Big Deal... or Not?
 
Vocera investordeck may 25 web 2018
Vocera investordeck  may 25 web 2018Vocera investordeck  may 25 web 2018
Vocera investordeck may 25 web 2018
 
Nvta investor overview may 2016
Nvta investor overview may 2016Nvta investor overview may 2016
Nvta investor overview may 2016
 
Managing National Health: An Overview of Metrics & Options
Managing National Health: An Overview of Metrics & OptionsManaging National Health: An Overview of Metrics & Options
Managing National Health: An Overview of Metrics & Options
 
Microsoft: A Waking Giant in Healthcare Analytics and Big Data
Microsoft: A Waking Giant in Healthcare Analytics and Big DataMicrosoft: A Waking Giant in Healthcare Analytics and Big Data
Microsoft: A Waking Giant in Healthcare Analytics and Big Data
 
Investor Presentation
Investor PresentationInvestor Presentation
Investor Presentation
 
Red Chip April Virtual Conf Investor Presentation April 2017
Red Chip April Virtual Conf Investor Presentation April 2017Red Chip April Virtual Conf Investor Presentation April 2017
Red Chip April Virtual Conf Investor Presentation April 2017
 
Vocera investordeck -may-15-2018web
Vocera investordeck -may-15-2018webVocera investordeck -may-15-2018web
Vocera investordeck -may-15-2018web
 
Cancer Genetics Earnings Call
Cancer Genetics Earnings CallCancer Genetics Earnings Call
Cancer Genetics Earnings Call
 

Similar to Vocera investordeck october 2017 for web

Vocera investordeck may 12 2017 needham
Vocera investordeck   may 12 2017 needhamVocera investordeck   may 12 2017 needham
Vocera investordeck may 12 2017 needhamvocera2016ir
 
Vocera investordeck march 2017
Vocera investordeck   march 2017Vocera investordeck   march 2017
Vocera investordeck march 2017vocera2016ir
 
Vocera investordeck february 2018 web
Vocera investordeck  february 2018 webVocera investordeck  february 2018 web
Vocera investordeck february 2018 webvocera2016ir
 
Vocera investordeck may 2018 web
Vocera investordeck  may 2018 webVocera investordeck  may 2018 web
Vocera investordeck may 2018 webvocera2016ir
 
Investor Presentation - April 2018
Investor Presentation - April 2018Investor Presentation - April 2018
Investor Presentation - April 2018vocera2016ir
 
Vocera investordeck february 2017 web (1)
Vocera investordeck   february 2017 web (1)Vocera investordeck   february 2017 web (1)
Vocera investordeck february 2017 web (1)vocera2016ir
 
Vocera investordeck may 15 2018 web
Vocera investordeck  may 15 2018 webVocera investordeck  may 15 2018 web
Vocera investordeck may 15 2018 webvocera2016ir
 
Vocera Investor Deck Feb 2017
Vocera Investor Deck Feb 2017Vocera Investor Deck Feb 2017
Vocera Investor Deck Feb 2017vocera2016ir
 
Vocera investordeck february 2017
Vocera investordeck   february 2017 Vocera investordeck   february 2017
Vocera investordeck february 2017 vocera2016ir
 
Vocera february 2017 web
Vocera february 2017 webVocera february 2017 web
Vocera february 2017 webvocera2016ir
 
Vocerainvestordeck january-2017final-web
Vocerainvestordeck  january-2017final-webVocerainvestordeck  january-2017final-web
Vocerainvestordeck january-2017final-webvocera2016ir
 
Vocera investordeck december web
Vocera investordeck  december webVocera investordeck  december web
Vocera investordeck december webvocera2016ir
 
Vocera investordeck march 2018 for web
Vocera investordeck  march 2018 for webVocera investordeck  march 2018 for web
Vocera investordeck march 2018 for webvocera2016ir
 
HealthSaaS Overview Deck October 2014 (RPM, Home Health)
HealthSaaS Overview Deck October 2014 (RPM, Home Health)HealthSaaS Overview Deck October 2014 (RPM, Home Health)
HealthSaaS Overview Deck October 2014 (RPM, Home Health)HealthSaaS, Inc.
 
Nobilis health corporate presentation march 3.23.18 final[2]
Nobilis health corporate presentation march 3.23.18 final[2]Nobilis health corporate presentation march 3.23.18 final[2]
Nobilis health corporate presentation march 3.23.18 final[2]IRNobilisHealth
 
Exas may 2017 corporate presentation final1
Exas may 2017 corporate presentation   final1Exas may 2017 corporate presentation   final1
Exas may 2017 corporate presentation final1Exact Sciences
 
Nhc corporate presentation july 12, 2016
Nhc corporate presentation july 12, 2016Nhc corporate presentation july 12, 2016
Nhc corporate presentation july 12, 2016IRNobilisHealth
 
Nhc corporate presentation july 12, 2016
Nhc corporate presentation july 12, 2016Nhc corporate presentation july 12, 2016
Nhc corporate presentation july 12, 2016IRNobilisHealth
 

Similar to Vocera investordeck october 2017 for web (20)

Vocera investordeck may 12 2017 needham
Vocera investordeck   may 12 2017 needhamVocera investordeck   may 12 2017 needham
Vocera investordeck may 12 2017 needham
 
Vocera investordeck march 2017
Vocera investordeck   march 2017Vocera investordeck   march 2017
Vocera investordeck march 2017
 
Vocera investordeck february 2018 web
Vocera investordeck  february 2018 webVocera investordeck  february 2018 web
Vocera investordeck february 2018 web
 
Vocera investordeck may 2018 web
Vocera investordeck  may 2018 webVocera investordeck  may 2018 web
Vocera investordeck may 2018 web
 
Investor Presentation - April 2018
Investor Presentation - April 2018Investor Presentation - April 2018
Investor Presentation - April 2018
 
Vocera investordeck february 2017 web (1)
Vocera investordeck   february 2017 web (1)Vocera investordeck   february 2017 web (1)
Vocera investordeck february 2017 web (1)
 
Vocera investordeck may 15 2018 web
Vocera investordeck  may 15 2018 webVocera investordeck  may 15 2018 web
Vocera investordeck may 15 2018 web
 
Vocera Investor Deck Feb 2017
Vocera Investor Deck Feb 2017Vocera Investor Deck Feb 2017
Vocera Investor Deck Feb 2017
 
Vocera investordeck february 2017
Vocera investordeck   february 2017 Vocera investordeck   february 2017
Vocera investordeck february 2017
 
Vocera february 2017 web
Vocera february 2017 webVocera february 2017 web
Vocera february 2017 web
 
Vocerainvestordeck january-2017final-web
Vocerainvestordeck  january-2017final-webVocerainvestordeck  january-2017final-web
Vocerainvestordeck january-2017final-web
 
Vocera investordeck december web
Vocera investordeck  december webVocera investordeck  december web
Vocera investordeck december web
 
Vocera investordeck march 2018 for web
Vocera investordeck  march 2018 for webVocera investordeck  march 2018 for web
Vocera investordeck march 2018 for web
 
Profile presentation to KHAC
Profile presentation to KHACProfile presentation to KHAC
Profile presentation to KHAC
 
HealthSaaS Overview Deck October 2014 (RPM, Home Health)
HealthSaaS Overview Deck October 2014 (RPM, Home Health)HealthSaaS Overview Deck October 2014 (RPM, Home Health)
HealthSaaS Overview Deck October 2014 (RPM, Home Health)
 
Nobilis health corporate presentation march 3.23.18 final[2]
Nobilis health corporate presentation march 3.23.18 final[2]Nobilis health corporate presentation march 3.23.18 final[2]
Nobilis health corporate presentation march 3.23.18 final[2]
 
Ir deck 8816 final
Ir deck 8816 finalIr deck 8816 final
Ir deck 8816 final
 
Exas may 2017 corporate presentation final1
Exas may 2017 corporate presentation   final1Exas may 2017 corporate presentation   final1
Exas may 2017 corporate presentation final1
 
Nhc corporate presentation july 12, 2016
Nhc corporate presentation july 12, 2016Nhc corporate presentation july 12, 2016
Nhc corporate presentation july 12, 2016
 
Nhc corporate presentation july 12, 2016
Nhc corporate presentation july 12, 2016Nhc corporate presentation july 12, 2016
Nhc corporate presentation july 12, 2016
 

More from vocera2016ir

Vocera ir master_ may 2019 web-converted
Vocera ir master_ may 2019 web-convertedVocera ir master_ may 2019 web-converted
Vocera ir master_ may 2019 web-convertedvocera2016ir
 
Vocera ir master_ april 2019 web
Vocera ir master_  april 2019 webVocera ir master_  april 2019 web
Vocera ir master_ april 2019 webvocera2016ir
 
Vocera ir march 2019 web
Vocera ir  march 2019 webVocera ir  march 2019 web
Vocera ir march 2019 webvocera2016ir
 
Vocera ir master_ february 2019 web
Vocera ir master_ february 2019 webVocera ir master_ february 2019 web
Vocera ir master_ february 2019 webvocera2016ir
 
Vocera jp morgan_1 2 19 2pm final
Vocera jp morgan_1 2 19 2pm finalVocera jp morgan_1 2 19 2pm final
Vocera jp morgan_1 2 19 2pm finalvocera2016ir
 
Vocera investordeck web january 2018 (1)
Vocera investordeck  web january 2018 (1)Vocera investordeck  web january 2018 (1)
Vocera investordeck web january 2018 (1)vocera2016ir
 
Vocera investordeck web january 2018
Vocera investordeck  web january 2018Vocera investordeck  web january 2018
Vocera investordeck web january 2018vocera2016ir
 

More from vocera2016ir (7)

Vocera ir master_ may 2019 web-converted
Vocera ir master_ may 2019 web-convertedVocera ir master_ may 2019 web-converted
Vocera ir master_ may 2019 web-converted
 
Vocera ir master_ april 2019 web
Vocera ir master_  april 2019 webVocera ir master_  april 2019 web
Vocera ir master_ april 2019 web
 
Vocera ir march 2019 web
Vocera ir  march 2019 webVocera ir  march 2019 web
Vocera ir march 2019 web
 
Vocera ir master_ february 2019 web
Vocera ir master_ february 2019 webVocera ir master_ february 2019 web
Vocera ir master_ february 2019 web
 
Vocera jp morgan_1 2 19 2pm final
Vocera jp morgan_1 2 19 2pm finalVocera jp morgan_1 2 19 2pm final
Vocera jp morgan_1 2 19 2pm final
 
Vocera investordeck web january 2018 (1)
Vocera investordeck  web january 2018 (1)Vocera investordeck  web january 2018 (1)
Vocera investordeck web january 2018 (1)
 
Vocera investordeck web january 2018
Vocera investordeck  web january 2018Vocera investordeck  web january 2018
Vocera investordeck web january 2018
 

Recently uploaded

Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024Osisko Gold Royalties Ltd
 
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call GirlsPremium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girlsmeghakumariji156
 
Teekay Tankers Q1-24 Earnings Presentation
Teekay Tankers Q1-24 Earnings PresentationTeekay Tankers Q1-24 Earnings Presentation
Teekay Tankers Q1-24 Earnings PresentationTeekay Tankers Ltd
 
Camil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCamil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCAMILRI
 
Osisko Development - Investor Presentation - May 2024
Osisko Development - Investor Presentation - May 2024Osisko Development - Investor Presentation - May 2024
Osisko Development - Investor Presentation - May 2024Philip Rabenok
 
Western Copper and Gold - May 2024 Presentation
Western Copper and Gold - May 2024 PresentationWestern Copper and Gold - May 2024 Presentation
Western Copper and Gold - May 2024 PresentationPaul West-Sells
 
Financial Results for the Fiscal Year Ended March 2024
Financial Results for the Fiscal Year Ended March 2024Financial Results for the Fiscal Year Ended March 2024
Financial Results for the Fiscal Year Ended March 2024KDDI
 
Terna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results PresentationTerna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results PresentationTerna SpA
 
The Leonardo 1Q 2024 Results Presentation
The Leonardo 1Q 2024 Results PresentationThe Leonardo 1Q 2024 Results Presentation
The Leonardo 1Q 2024 Results PresentationLeonardo
 
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...Klinik kandungan
 
Camil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCamil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCAMILRI
 
AMG Quarterly Investor Presentation May 2024
AMG Quarterly Investor Presentation May 2024AMG Quarterly Investor Presentation May 2024
AMG Quarterly Investor Presentation May 2024gstubel
 
Gorakhpur Call Girls 8250092165 Low Price Escorts Service in Your Area
Gorakhpur Call Girls 8250092165 Low Price Escorts Service in Your AreaGorakhpur Call Girls 8250092165 Low Price Escorts Service in Your Area
Gorakhpur Call Girls 8250092165 Low Price Escorts Service in Your Areameghakumariji156
 
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In DubaiDubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubaikojalkojal131
 
Corporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdfCorporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdfProbe Gold
 
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样sovco
 
countries with the highest gold reserves in 2024
countries with the highest gold reserves in 2024countries with the highest gold reserves in 2024
countries with the highest gold reserves in 2024Kweku Zurek
 

Recently uploaded (20)

ITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdf
ITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdfITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdf
ITAU EQUITY_STRATEGY_WARM_UP_20240505 DHG.pdf
 
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
Osisko Gold Royalties Ltd - Corporate Presentation, May 2024
 
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call GirlsPremium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
Premium Call Girls In Kapurthala} 9332606886❤️VVIP Sonya Call Girls
 
Teekay Tankers Q1-24 Earnings Presentation
Teekay Tankers Q1-24 Earnings PresentationTeekay Tankers Q1-24 Earnings Presentation
Teekay Tankers Q1-24 Earnings Presentation
 
Camil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCamil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdf
 
Osisko Development - Investor Presentation - May 2024
Osisko Development - Investor Presentation - May 2024Osisko Development - Investor Presentation - May 2024
Osisko Development - Investor Presentation - May 2024
 
Osisko Gold Royalties Ltd - Q1 2024 Results
Osisko Gold Royalties Ltd - Q1 2024 ResultsOsisko Gold Royalties Ltd - Q1 2024 Results
Osisko Gold Royalties Ltd - Q1 2024 Results
 
Western Copper and Gold - May 2024 Presentation
Western Copper and Gold - May 2024 PresentationWestern Copper and Gold - May 2024 Presentation
Western Copper and Gold - May 2024 Presentation
 
Financial Results for the Fiscal Year Ended March 2024
Financial Results for the Fiscal Year Ended March 2024Financial Results for the Fiscal Year Ended March 2024
Financial Results for the Fiscal Year Ended March 2024
 
Terna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results PresentationTerna - 1Q 2024 Consolidated Results Presentation
Terna - 1Q 2024 Consolidated Results Presentation
 
The Leonardo 1Q 2024 Results Presentation
The Leonardo 1Q 2024 Results PresentationThe Leonardo 1Q 2024 Results Presentation
The Leonardo 1Q 2024 Results Presentation
 
SME IPO Opportunity and Trends of May 2024
SME IPO Opportunity and Trends of May 2024SME IPO Opportunity and Trends of May 2024
SME IPO Opportunity and Trends of May 2024
 
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
Jual obat aborsi Tawangmangu ( 085657271886 ) Cytote pil telat bulan penggugu...
 
Camil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdfCamil Institutional Presentation_Mai24.pdf
Camil Institutional Presentation_Mai24.pdf
 
AMG Quarterly Investor Presentation May 2024
AMG Quarterly Investor Presentation May 2024AMG Quarterly Investor Presentation May 2024
AMG Quarterly Investor Presentation May 2024
 
Gorakhpur Call Girls 8250092165 Low Price Escorts Service in Your Area
Gorakhpur Call Girls 8250092165 Low Price Escorts Service in Your AreaGorakhpur Call Girls 8250092165 Low Price Escorts Service in Your Area
Gorakhpur Call Girls 8250092165 Low Price Escorts Service in Your Area
 
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In DubaiDubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
Dubai Call Girls/// Hot Afternoon O525547819 Call Girls In Dubai
 
Corporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdfCorporate Presentation Probe Canaccord Conference 2024.pdf
Corporate Presentation Probe Canaccord Conference 2024.pdf
 
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
一比一原版(EUR毕业证书)鹿特丹伊拉斯姆斯大学毕业证原件一模一样
 
countries with the highest gold reserves in 2024
countries with the highest gold reserves in 2024countries with the highest gold reserves in 2024
countries with the highest gold reserves in 2024
 

Vocera investordeck october 2017 for web

  • 2. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. This presentation contains forward-looking statements reflecting our current expectations that involve risks and uncertainties which are subject to safe harbors under the Securities Act of 1933, as amended, or the Securities Act, and the Securities Exchange Act of 1934, as amended, or the Exchange Act. These forward-looking statements may include, but are not limited to, statements concerning our plans, objectives, expectations and intentions, future financial position, future revenues, projected costs, expectations regarding demand and acceptance for our technologies, growth opportunities and trends in the market in which we operate, prospects and plans and objectives of management. The words “anticipates,” “believes,” “estimates," “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation, the risks set forth in Part II, Item 1A, “Risk Factors” in our Quarterly Reports on Form 10-Q and in our other filings with the Securities and Exchange Commission. We do not assume any obligation to update any forward-looking statements. 2 Forward-Looking Statements
  • 3. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. VOCERA We simplify and improve the lives of healthcare professionals, patients, and families A recognized leader in clinical communication and workflow solutions Founded in 2000 HQ: San Jose, CA ~600 employees 40+ clinician staff 1,100 US Hospitals 1,400 Customers 99% Maintenance Renewals Proven ROI 20%+ Rev. Growth Operating Leverage Strong balance sheet (NYSE: VCRA) 68 VA Hospitals 32 DoD Hospitals JITC, DIACAP, FIPS certified ©2017 Vocera Communications. All rights reserved. 3
  • 4. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. 4 • Large market shifting toward Vocera • Market leader with compelling ROI • Large wins validate sales strategy • Software acquisition extends platform • Accelerating operating leverage *Earnings before interest, taxes, depreciation and amortization, and further excludes stock -based compensation and change in fair value of warrant and option liabilities. **Represents the high end of the company’s guidance range Our Opportunity $95 $104 $128 $162 -13% -3% 3% 6% -15% -10% -5% 0% 5% 10% 0 20 40 60 80 100 120 140 160 180 FY14 FY15 FY16 FY17 Guide - High Revenue $M A-EBITDA %
  • 5. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. (1) Joint Commission, an independent healthcare accreditation organization (2) Agarwal et. al. Univ. of Maryland, 2010 92% of physicians use unsecured SMS text for patient care, leading to data breeches and HIPAA violations resulting in over $1.5M in fines per year Efficient communication is a primary component in driving patient engagement and satisfaction Nurses often only spend 20% of their time delivering direct care at the patient bedside 69% of accidental deaths and serious injuries in hospitals are caused by communications breakdowns1 Cybercriminals are increasingly going after targets in the medical and healthcare verticals $12 billion wasted annually In U.S. hospitals as a result of communication inefficiencies2 5 Healthcare Communication Challenges
  • 6. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. Vocera Before Vocera Now Communications Badge-Centric Point Product Department Sale Clinical Workflow Software-Centric Complete Solution Enterprise Sale Strategic Evolution 6
  • 7. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. 7 10 minutes per nurse per shift Bed turnover rates up 50% OR revenues up $780,000 350 more annual OR capacity hours 4,000 annual ED hours recaptured Operational Efficiency Response times down from 2 minutes to 9 seconds 35% overall satisfaction rating improvement 25% improvement in HCAHPS scores Fall related injuries down 60%; estimated $1.27 mm savings Patient Safety and Satisfaction Compelling Return on Investment
  • 8. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. 8 MEDCOM Recent Platform Wins Validate Strategy
  • 9. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. Quality ResiliencyPatient-CenteredCost Enhance how care is provided to help patients to achieve better outcomes Increase operational efficiencies Improve patient experience by allowing caregivers to be Patient Centered Improve the caregiver experience by improving workflow and empowering care teams The Quadruple Aim 9 Our Mission
  • 10. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. 10 Communicate Engage Experience Improve response times, patient care, safety and satisfaction Over 120 clinical integrations Secure text, voice, image Clinical Communication and Collaboration
  • 11. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. Vocera Platform Enables the Patient Journey Clinical Communication Smartphones and Wearable Devices Care ExperienceStaff Assignment Alarm and Alert Management System Integration and Interoperability Security Compliance The Patient Journey Clinical Expertise Enterprise Grade, Scalable Obtain, clarify, change orders Patient status Test results Admission, discharge, transfer Nurse- physician consult Patient Flow 11
  • 12. Vocera’s Enterprise Approach 12 Today’s Situation Product Vision - A Holistic, Enterprise Approach Alerts Alarms Messaging Voice
  • 13. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. Communicate, Collaborate, Make Informed Decisions Quickly PHYSICIAN  Collaborate whether inside or outside the hospital NURSE Reach the right person without names or numbers NURSE SUPERVISOR Keep nurses and patients safer HOSPITALIST Receive timely, relevant patient information HOUSEKEEPING Increase bed turnover Alert & Alarm Intelligence Electronic Health Record Nurse Call Physiologic Monitor Bed Management Real-Time Location System Laboratory Info System INPUTS Dynamic Data Aggregation of Patient Events and Context OUTPUTS Context-Aware Events Response and Critical Collaboration Dynamic Master Directory
  • 14. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. Device of Choice Differentiator Hands-Free BYOD or in House Tablet Desktop/ WOW 14
  • 15. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. 15  Complete end-to-end solution  Device of choice  Hands-free  Role-based intelligence = we win > 75% of the time  Enterprise Class  Clinical integration  Secure  World class service/support Competitive LandscapeStatusQuo Wireless Devices Smartphone Apps
  • 16. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. 6,986 Hospitals in the U.S.(1) U.S. Hospitals 1100+ (1) Large Global Market Opportunity (1 ) Based on Definitive US Healthcare Database. As of January 1, 2017 (2) Definitive Healthcare database International Healthcare Facilities 230+ Global Non- Healthcare Facilities 270+ Fed Hospitals Vocera Total VA 68 153 DoD 32 64 Total 100 217 ~$6 Billion Global Market Opportunity 16 1108 5200 Vocera Hospitals US Hospitals 18% U.S. Penetration Rate (2) (6308 Total US Hospitals)
  • 17. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. • Large system deals • Further penetrate existing health system customers • Continue pace of new customer acquisition Building momentum across new products • EHR Integration • Collaboration Suite • Clinical Integration • Event Driven Alerts • Care Experience Extend reach to new users • Physicians • Long Term Care • Surgery Centers Attractive international markets • Canada • United Kingdom • Saudi Arabia • UAE • Qatar • Australia • New Zealand Core Customer Growth Software New Users International Expansion 17 Our Opportunity: Multiple Avenues for Growth
  • 18. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. Software *15%+ subscription 18 % of 2016 Revenue 16% Maintenance *All recurring 34% Services *15%+ recurring 11% 39% Devices *50% recurring Diversified Revenue, High Visibility • 60% revenues are recurring • High visibility • Low customer concentration
  • 19. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. (1) Earnings before interest, taxes, depreciation and amortization, and further excludes stock -based compensation and change in fair value of warrant and option liabilities. Revenue Highlights Adjusted EBITDA $33.8 $42.3 $91.7 $117.0 Q316 Q317 YTD '16 YTD '17 ($inMillions) -$2.8 $4.3 2015 2016 ($inMillions) Strong Revenue Growth • Q3’17: 25% Revenue Growth • Product: +20%, Services: +32% • YTD’17: 27% Revenue Growth Solid Customer Base and Value Proposition • 95%+ s/w maintenance renewal rate • Strong competitive win rate Expanding Profitability and Cash Flow • 2017 A-EBITDA guidance: $7.0 -10.5 million • $67.5 million of Cash, no Debt 19 +25% +27% Financial Highlights
  • 20. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. 20 Q4’17 Revenue Visibility Rev from Def. Rev/BL Supplies Visible Revenue Book-ship Q4'17 Revenue $45M* (*high end of guidance)
  • 21. ©2017 Vocera Communications. All rights reserved.©2017 Vocera Communications. All rights reserved. 21 Actual 2014 2015 2016 R&D % of Revenue 17% 15% 13% S&M % of Revenue 47% 41% 37% G&A % of Revenue 13% 12% 11% Target Model 12% 29% 8% Sales Notes • All numbers are non-GAAP • Mean peer group enterprise value comps are 3-4x Revenue and 12-15x A-EBITDA Drivers Operating Leverage Drives Significant Value